AcroMeta Group Limited (SGX:43F)
0.0240
+0.0010 (4.35%)
At close: Aug 8, 2025
Intra-Cellular Therapies Market Cap
AcroMeta Group has a market cap or net worth of 7.47 million as of August 12, 2025. Its market cap has decreased by -27.14% in one year.
Market Cap
7.47M
Enterprise Value
7.87M
Revenue
5.69M
Ranking
n/a
PE Ratio
3.98
Stock Price
$0.02
Market Cap Chart
Since April 18, 2016, AcroMeta Group's market cap has decreased from 31.27M to 7.47M, a decrease of -76.11%. That is a compound annual growth rate of -14.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 7.47M | -21.43% |
Dec 30, 2024 | 9.51M | 14.37% |
Dec 28, 2023 | 8.31M | 46.34% |
Dec 30, 2022 | 5.68M | -47.44% |
Dec 16, 2021 | 10.81M | -19.59% |
Dec 30, 2020 | 13.44M | 22.78% |
Dec 6, 2019 | Upgrade Pro | Upgrade Pro |
Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Apr 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
DBS Group Holdings | 143.97B |
Oversea-Chinese Banking Corporation | 75.46B |
Singapore Telecommunications | 65.72B |
United Overseas Bank | 59.27B |
Singapore Technologies Engineering | 27.13B |
Jardine Matheson Holdings | 21.04B |
Singapore Airlines | 19.76B |
Wilmar International | 18.48B |